GLP-1 Drugs Linked to Lower Liver and Kidney Risks in Viral Hepatitis
In U.S. claims data, GLP-1 receptor agonists were associated with lower cirrhosis, HCC, and CKD risks in type 2 diabetes with chronic viral hepatitis.
This section contains the website’s posts.